David A. Evans
Nessuna posizione attualmente
Storia della carriera di David A. Evans
Precedenti posizioni note di David A. Evans
Società | Posizione | Inizio | Fine |
---|---|---|---|
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | Amministratore Delegato | 01/01/2021 | 02/01/2024 |
Presidente | 01/01/2021 | 02/01/2024 | |
First Genetic Trust, Inc.
First Genetic Trust, Inc. Medical/Nursing ServicesHealth Services First Genetic Trust, Inc. provides genetic data handling and bioinformatics services to pharmaceutical companies, medical researchers and health care providers. The company was founded in 2000 by Arthur L. Holden and is headquartered in Deerfield, IL. | Direttore Tecnico/Scientifico/R&S | - | - |
Octagon Research Solutions, Inc.
Octagon Research Solutions, Inc. Information Technology ServicesTechnology Services Octagon Research Solutions, Inc. provides software services to the pharmaceutical sectors. The company was founded by James C. Walker in 1999 and is headquartered in King of Prussia, PA. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di David A. Evans
Ursinus College | Undergraduate Degree |
Drexel University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Settori
Consumer Services | 3 |
Technology Services | 2 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Octagon Research Solutions, Inc.
Octagon Research Solutions, Inc. Information Technology ServicesTechnology Services Octagon Research Solutions, Inc. provides software services to the pharmaceutical sectors. The company was founded by James C. Walker in 1999 and is headquartered in King of Prussia, PA. | Technology Services |
First Genetic Trust, Inc.
First Genetic Trust, Inc. Medical/Nursing ServicesHealth Services First Genetic Trust, Inc. provides genetic data handling and bioinformatics services to pharmaceutical companies, medical researchers and health care providers. The company was founded in 2000 by Arthur L. Holden and is headquartered in Deerfield, IL. | Health Services |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | Commercial Services |
- Borsa valori
- Insiders
- David A. Evans
- Esperienza